LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia

Photo from wikipedia

Key Points • Long-term romiplostim treatment is effective in children with primary ITP; serial bone marrow biopsy results showed no new safety concerns.• Romiplostim injections resulted in 8 AEs of… Click to show full abstract

Key Points • Long-term romiplostim treatment is effective in children with primary ITP; serial bone marrow biopsy results showed no new safety concerns.• Romiplostim injections resulted in 8 AEs of neutralizing antibodies (romiplostim, n = 7 [transient n = 4]; TPO, n = 1 [transient n = 1]).

Keywords: long term; safety; romiplostim; arm long; single arm; term

Journal Title: Blood Advances
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.